chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had severe muscle pain and joint pains. Worst muscle pain was in shoulders and worst joint pain was in right ankle and right hip joint. No swelling. I have chills and low-grade fever. Symptoms started about 1-2 hours after injection and peaked about 12-15 hours later. Some mild pain persisted for 72 hours. Self treated with prednisone X 2 days.
Longer than Recommended Interval; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (patient received one dose of Shingrix 5 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Longer than Recommended Interval).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 06-OCT-2023 The physician reported that the patient was wondering if he got one dose of Shingrix 5 years ago. The reporter asked if patient should restart the series or just get one more dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
8/11/08 patient states she has had a fever 20 minutes after she received vaccines and still has fever today.  8/11/08 states she has headache and pain in arm and feels achy.  State Tylenol and Motrin do not control fever reported to MD.  Saw doctor 8/11/08.  8/27/08 mom said child recovered.
I first developed symptoms on 5/17/22. Had a sore throat, post-nasal drip and laryngitis. Tested negative for COVID-19 on 5/18/22. Tested positive on 5/20/22. I called my doctor that day and received Paxlovid. I took Paxlovid for 5 days and felt great afterward. The symptoms started again the afternoon of 5/29/22. I lost my tasted and smell and developed severe fatigue and a cough which continued until 6/5/22. I developed vertigo on 6/6/22 and tested negative that evening. Tested negative again on 6/7/22. I had a tele-med check-in w/my doctor on 6/7/22 who advised me to just rest, liquids and Tylenol. Symptoms began to lessen in the following days. Fatigue and dizziness has persisted but I am consistently testing negative.
Breakthrough case after 2nd vaccine Pfizer 7/14/21 Lot# FA6780;  Pfizer 8/4/21 Lot# FC318
fatigue; unable to get up on his own; heavy breathing; thick mucus; increased confusion; Weakness; severe muscle weakness; unable to sleep; aches and pains; arm was sore; This is a spontaneous report from a contactable consumer (patient's son). A 93-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9261, Expiration date: Unknown) via an unspecified route of administration in the left arm on 24Jan2021 at 13:30 (at the age of 93-year-old) as 1st dose, single dose for COVID-19 immunization in hospital. Medical history included muscle relaxant, blood pressure or cholesterol and broken neck from 1978 to an unknown date and unknown if ongoing. Concomitant medications included ongoing atorvastatin calcium 10mg taken once daily by mouth for blood pressure or cholesterol taking for a while, ongoing propafenone hydrochloride 150mg taken one twice daily by mouth, taking for a while, ongoing baclofen 10mg taken one five times daily by mouth as muscle relaxant taking for years, ongoing diltiazem HCL 180mg taken once daily by mouth, taking for long time, ongoing mirtazapine 30mg taken one at bedtime by mouth, taking for a while, ongoing citalopram HBR 20mg take once daily by mouth, taking for a while. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Jan2021, the patient experienced unable to sleep, aches and pains, arm was sore, on 25Jan2021, experienced weakness, severe muscle weakness, on 26Jan2021, experienced increased confusion and on an unspecified date, experienced fatigue, unable to get up on his own, heavy breathing and thick mucus. But his father has tremendously decreased. Mentions his father was previously independent, using a walker, going to exercise class by himself and totally fine. Now after receiving the vaccine his father is unable to sleep, has aches and pains, was experiencing increased confusion and profound weakness. Adds his father can't get up on his own and has to be guided to use the walker if he can get up. They did call his HCP and were advised not to get the second dose and to make sure patient was eating and drinking. He was scheduled to receive the second dose on 14Feb2021 but he was unsure if he will get it. Adds his father had been water walking everyday and this wasn't like him. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Patient called HD on 02/19/15 AM to report concerns that his Lt hand was hurting him through the night. When he woke up, his Lt middle finger knuckle was swollen and red and difficult to move his hand due to the pain. He reported swelling at knuckle about the size of a "nickel". Denies any fever this morning or other symptoms. No swelling, redness or pain in any other fingers, hand or shoulder. He states last night his upper arm was a little tender at injection site and he thinks he might have had a mild fever but those have resolved now. I encouraged him to take some NSAIDS and monitor closely. If any swelling, redness or pain moves further into hand or other fingers, he will need to see his doctor. I attempted to follow up with him that afternoon but he did not answer phone as "he was out all day". I spoke with him the next day and he said his finger was doing better. Still a little swollen with very little redness and no more pain but just "felt a little funny due to swelling". He denied any spread of symptoms into other hand or fingers and he was able to move his hand and fingers today without problem. We discussed some education on vaccinations and possible reactions. I encouraged him to continue at least a daily dose of NSAIDS until fully resolved and again to call ASAP and/or see doctor if any symptoms worsened. I was not able to follow up with client any further as he did not answer the phone after several daily attempts over the next 4-5 days and unable to leave a message. He had been given my information to call if further concerns at last conversation.
BLURRED VISION AND  COULDN'T FOCUS AND THEN DOUBLE VISION IN RIGHT EYE AND  COULD NOT DRIVE SO HE HAD TO GO SEE HIS OPTHAMOLOGIST. THEN HE SAW A NEUROLOGIST WITH A DX GIANT CELL ARTERIES WHICH CAUSED A BLOCKAGE TO THE LEFT EYE.
Developed hives all over the body within 1/2 hr of shot. no other symptoms.
Pt received second dose Pfizer COVID vaccine 1/7/21. On 1/8/21 t 8 PM developed fever and chills, T-max 100.4, as well as a dry cough and headache. No shortness of breath or chest pain or wheezing. No sore throat. Virtual Urgent Care visit 1/9/21. COVID test negative. No treatment performed, no escalation of care.
8 hrs after vaccine local tenderness, took tylenol. next morning (16-18hrs post shot) local redness and pain redness did not increase but persisted 2 days.
2nd dose was administered more than 42 days after the first dose; Expired 2nd dose administered to patient/patient received expired 2nd dose of Moderna; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was administered more than 42 days after the first dose) and EXPIRED PRODUCT ADMINISTERED (Expired 2nd dose administered to patient/patient received expired 2nd dose of Moderna) in a 21-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 012F21A and 045C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Dec-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 05-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 05-May-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was administered more than 42 days after the first dose) and EXPIRED PRODUCT ADMINISTERED (Expired 2nd dose administered to patient/patient received expired 2nd dose of Moderna). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was administered more than 42 days after the first dose) and EXPIRED PRODUCT ADMINISTERED (Expired 2nd dose administered to patient/patient received expired 2nd dose of Moderna) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  The reporter stated that the expiration date was from CDC. According to CDC expiration date 19 Mar 2022 was the last updated on this lot.  No treatment medications was reported.   Reporter did not allow further contact
Hives all over body. Experienced two nights in a row. Had to go to Emergency Room
swelling from site to face/eyelid and down arm. Followed by very sharp pain in hand on extension.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in right arm and as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Ra" (unspecified if ongoing); "psoriatic" (unspecified if ongoing); "meniere" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "depression" (unspecified if ongoing); "GERD" (unspecified if ongoing) and menierries. Concomitant medication(s) included/Other medication in 2 weeks: CIMZIA; PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; CRESTOR; FUROSIMIDE; AMITRIPTYLINE; WELLBUTRIN; VITAMIN D [COLECALCIFEROL]; MAGNESIUM; CALCIUM; COQ10 + D3. Past drug history included: Sulphate drugs, reaction(s): "drug allergy"; Ceclor, reaction(s): "drug allergy"; Steroidz, reaction(s): "drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: unknon results, notes: Indication: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti viral details: brand=Paxlovid, Treatment start date=11Jun2022, treatment stop date=12Jun2022.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
Information has been received from a physician concerning a 2 month old female who, on 18-AUG-2008, was vaccinated with a first dose of ROTATEQ, oral.  Three days later, on 21-AUG-2008, the patient experienced hematochezia which was described as "light spotting".  One week later, on 28-AUG-2008 the patient again experienced hematochezia also described as "light spotting".  Unspecified medical attention was sought.  Subsequently, the patient recovered from both events of hematochezia (dates unknown).  No product quality complaints were involved.  Hematochezia was considered to be an other important medical event.  Additional information has been requested.
5 days after the 2nd dose I started to lose taste in my mouth. I can still smell and taste things at the back of my mouth, but the front of my tongue feels numb.
Information has been received from a physician concerning a 78 year old male who on 28-SEP-2007, was vaccinated with zoster vaccine live (Oka/Merck) (Lot# 658212/0887U). On 28-SEP-2007, the patient experienced severe painful injection site reaction and a rash at the injection site that extended to his wrist. On 05-OCtT-2007, the patient experienced shingles. The physician reported the patient did not experience any lesions/reaction at the injection site. On 09-Oct-2007, a specimen was obtained from a lesion on the patients left arm for varecella zoster virus identification that was reported as positive for wild type strain. The patient is being treated with FAMVIR. Additional information has been requested.
Patient arrived for third Pfizer vaccine. The patient was 4 when she started the series and turned 5 before her third vaccine dose. Pfizer bivalent 5 -11 year old was administered. She should have received Pfizer bivalent 6 month - 4 years. Once a 4 year old starts this series, they have to finish this series.
Difficulty breathing, retracting, gasping for breath, increased heart rate, low grade fever. Multiple doctors visits, emergency room visit, chest xray, tests, labs, incentive spirometer, etc. Nearly 3 months since vaccine and symptoms continue with no reasonable resolution no matter what has been attempted by providers. Have been prescribed spiriva, albuterol nebs and rescue inhalers, prednisone and claritin BID.  Have paid out of pocket thousands of dollars with no resolution. This vaccine has damaged my lungs and negatively impacted my life and health since march
Initial misuse report received from a healthcare professional on 07 August 2013. An 11-year-old patient was administered DAPTACEL vaccine. No more information was provided. No adverse event was reported. List of documents held by sender: none.
Initial unsolicited report received from a consumer on 15 October 2015. This case involves an 81-year-old female patient who was vaccinated with a dose of FLUZONE HD (Batch number, dose, dose in series, expiry date were not reported) via intramuscular route in left deltoid on 06 October 2015. The patient did not have any illness at the time of vaccination or any pre-existing physician diagnosed allergies, birth defects, medical conditions. Concomitant medications were not reported. On 06 October 2015, few seconds (immediately) following the vaccination, the patient had experienced pain in left deltoid. Three days following the vaccination, the patient had severe pain in the left arm that shot up to her neck and to the top of head. She had severe pain in her neck, difficulty swallowing, had a generalized pain and weakness throughout the body. Patient had difficulty getting in and out of bed and felt incapacitated. Laboratory data and corrective treatment were not reported. The patient had not recovered from the events. Upon medical review, the case was considered as serious due to important medical event: having difficulty getting in and out of bed/feels incapacitated. List of documents held by sender: none.
Covid test positive; Covid test positive; feeling bad/even worse; feel like sick; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumers (one of which is the patient) reported that a male patient of an unspecified age (reported as 45, no unit) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date then received the second dose on 19Jan2021 both via an unspecified route of administration at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient's second shot was on Tuesday (19Jan2021). He was feeling really bad Tuesday afternoon, and on Wednesday (20Jan2021) even worse. He worked in a laboratory. He took a COVID test Wednesday at work, and within two minutes of testing himself it said positive. They also have PCR test. He was wondering if the vaccination can cause false positives. He feel like he's sick, like there was something going on. The patient wasn't hospitalized. He was already sitting at home in quarantine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
less than 0.5mL administered; Some of the product leaked onto her arm; SSome of the product leaked onto her arm; This non-serious case was reported by a physician via call center representative and described the occurrence of underdose in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced underdose (Verbatim: less than 0.5mL administered), inadvertent exposure to vaccine (Verbatim: Some of the product leaked onto her arm) and exposure via skin contact (Verbatim: SSome of the product leaked onto her arm). The outcome of the underdose, inadvertent exposure to vaccine and exposure via skin contact were unknown.   Additional Information: GSK Receipt Date: 10-AUG-2023 The reporter reported that the patient received less than 0.5 ml of Shingrix vaccine during administration some of the product leaked onto her arm. The reporter stated that the lot number, expiration date and full patient demographics were not provided. The reporter did not provided additional details. The patient received less than 0.5 ml of Shingrix vaccine during administration some of the product leaked onto her, which led to underdose, exposure via skin contact and inadvertent exposure to vaccine. The reporter consented to follow up.
Aching and sharp pains in right arm, throbbing, painful that night 10/6/10, 10/7/10 pain decreased slowly, this morning 10/8/10 noticed redness. Site is reddened, warm to touch, swollen, painful with pressure, current temperature 99.8.
Lethargic; generalized itching; Unsure if got 2nd dose,  2nd dose Nov2021, 3rd 16oct2022; This case was reported by a consumer via call center representative and described the occurrence of lethargy in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE (FLU VACCINE (NAME UNKNOWN)) for prophylaxis.   Previously administered products included Shingrix (received 2nd dose on November 2021) and Shingrix (received 1st dose (0.5 ml) intramuscularly in August 2021).   On 16th October 2022, the patient received the 3rd dose of Shingrix (intramuscular) .5 ml and the 1st dose of FLU VACCINE (NAME UNKNOWN) (intramuscular). On 16th October 2022, unknown after receiving Shingrix and an unknown time after receiving FLU VACCINE (NAME UNKNOWN), the patient experienced extra dose administered. On 17th October 2022, the patient experienced lethargy and generalized pruritus. On an unknown date, the outcome of the lethargy and generalized pruritus were not recovered/not resolved and the outcome of the extra dose administered was unknown.   It was unknown if the reporter considered the lethargy and generalized pruritus to be related to Shingrix.     Additional Information: GSK Receipt Date: 17-OCT-2022 Reporter's Comment: The patient self-reported this case. The patient reported that she might had received possible third dose administered in right arm and also received Flu vaccine (non GSK) in left arm on the same day. One day after vaccination, the patient was lethargic and had generalized itching. Patient also reported that she was unsure if got the second Shingrix vaccine prior to yesterday's Shingrix vaccine and pharmacy had no record of patient receiving it. Patient potentially received a third Shingrix vaccine yesterday. Patient had not gotten a second vaccine prior to yesterday, then would have been past the 6 months for getting her second vaccine. It was unknown if the reporter considered the lethargy and pruritus to be related to Flu vaccine (non GSK).    Reporter consented to follow up. Additional supportive information: The patient received possible 3rd dose of Shingrix, which led to extra dose administered. Discrepancy for vaccine information in source document, hence dose and unit, route of administration and anatomical location were conservative capture for 3rd dose instead of 2nd, clarification has been raised.
Shot taken at pharmacy on Nov. 18, 2015 in muscle right arm. Woke up Nov. 19, 2015 right arm swollen, fever, red color from top of arm to elbow. Started taking BENADRYL tabs every 4 hours and apply BENADRYL salve to arm 3 day till arm looked normal.
Information has been received from a registered nurse concerning a 16 year old female with no previous drug reactions who on 26, Feb 2007, was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast) first dose. On 26, Feb 2007, the patient fainted after receiving HPV rL1 6 11 16 18 VLP vaccine (yeast). Unspecified medical attention was sought. The patient recovered from fainting the same day the vaccine was received. Additional information has been requested. This is in follow-up to report (s) previously submittedo n 4/6/2007. Initial follow up information has been received. Follow up information indicated that on 28-Feb-2007, the patient fainted (previously mentioned as on 26-Feb-2007) after receiving the first injection. Unspecified medical attention was sought. On 28-Feb-2007 patient recovered. Additional information is not expected.
8 cm x 8 cm area of eryth and induration Tdap 4-20-07
Patient received 2nd dose of Moderna on 9/6/2021  after receiving the first dose on 8/15/2021
Patient received vaccine on 2/17/15 SQ in the left arm. On 2/19/15, patient reported a burning sensation and tender to touch in the tricept region of the left arm from the armpit to the elbow. No rash, irritation, swelling, or redness was noted. Patient was still experiencing symptoms as of 3/20/15. Patient tried using aloe, Neosporin, lotion, hot pack and Aleve for the symptoms with no improvement.
Presented with fall; previous poss exposure to Covid; asymptomatic; fully vaccinated; treated with zinc; no PNA..admitted while finding SNF placement; d/c'ed to SNF.
I saw this 4-year-old child for infection in her lateral left thigh which developed at the site of 4 year vaccine injection.  The painful swelling persisted for over 2 months so she was instructed to bring her in for evaluation.  It is my impression that this is in injection site infection.  I have started therapy and I will be following her up closely.
The pt experienced an approximately 1 1/4 to 2 inch circle of redness with 1cm hard nodule in the center of circle. The area was sore and warm to the touch. No fever was noted.
tiredness; headache; Injection site pain; injection site swelling; swollen lymph nodes under arm; muscle pain; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot/batch number not reported, via an unspecified route of administration from 07Jan2021 12:45 to 07Jan2021 12:45 as SINGLE DOSE for COVID-19 immunisation. Medical history Known allergies: penicillin, almonds, raw carrots. Other medical history: Thyroid cancer, seasonal allergies, asthma. The patient previously tested positive for COVID-19 prior vaccination. The patient is not pregnant. The patient's concomitant medications were not reported. On 07Jan2021 18:00, the patient experienced injection site pain, tiredness, headache, muscle pain, injection site swelling, swollen lymph nodes under arm. The outcome of the events was not recovered.  Information about lot/batch number has been requested.
Patient states she woke up the day following her vaccine and had a really bad headache and felt "hungover". Pt. stated her eyes and ear lobes were very red and swollen. She stated her left eye was completely swollen shut. She states her eyes and ear were very puffy and itchy as well.
SEVERAL HOURS AFTER VACCINE PATIENT DEVELOPED A 102 FEVER. SOON AFTER SHE HAD A HEADACHE AND UPSET STOMACH. SYMPTOMS HAD NOT RESOLVED AS OF 6/23/20. PHARMACIST CALLED PATIENT ON 6/24/20 TO CHECK IN AND HAS NOT HEARD BACK.